Aqr Capital Management LLC Oramed Pharmaceuticals Inc. Transaction History

Aqr Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$3.72 - $9.0 $66,788 - $161,586	-17,954 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$8.19 - $13.89 $16,551 - $28,071	-2,021 Reduced 10.12%	17,954 $155,000
Q4 2021 Feb 14, 2022	SELL	$12.98 - $29.75 $33,696 - $77,231	-2,596 Reduced 11.5%	19,975 $285,000
Q3 2021 Nov 15, 2021	BUY	$12.13 - $23.82 $273,786 - $537,641	22,571 New	22,571 $496,000

7.4M

2.1K

Ticker ORMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,100
Market Cap $92.4M
Description
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aqr Capital Management LLC with notifications on news.